SCHEMBL1324048

SCHEMBL1324048

CC1(Oc2ccccc2)COC(=O)O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAOB P27338 2/20 0.35
NPC1 O15118 2/20 0.35
ALDH1A1 P00352 3/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPK1 P28482 2/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
UTS2R Q9UKP6 1/20 0.33
TSHR P16473 1/20 0.33
PPIB P23284 1/20 0.33
CFTR P13569 1/20 0.33
GOPC Q9HD26 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770245 0.79 ADRA2A (0.38) POLBL3MBTL1CYP1A2CYP2C9
SCHEMBL21038087 0.76 GAA (0.35) POLBL3MBTL1GAANPSR1MAOB
SCHEMBL8306987 0.76 MAOB (0.41) NPSR1MAOBNPC1ALDH1A1HPGD
SCHEMBL6321287 0.75 POLB (0.39) POLBL3MBTL1GAANPSR1MAOB
SCHEMBL338571 0.75 POLB (0.39) POLBL3MBTL1GAANPSR1MAOB
SCHEMBL21038861 0.73 MMP2 (0.33) POLBL3MBTL1GAANPSR1MAPK1
SCHEMBL21038053 0.72 GAA (0.35) GAANPSR1
SCHEMBL1324583 0.71
SCHEMBL22162655 0.71 MMP2 (0.37) POLBL3MBTL1GAANPSR1MAPK1
SCHEMBL22960999 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600887-B2 One-part adhesive for thermoplastic urethanes LORD CORPORATION (US) 2026-04-14 US disclosed
US-11916195-B2 Electrolyte solution, electrochemical device, lithium ion secondary battery, and module DAIKIN INDUSTRIES, LTD. (JP) 2024-02-27 US disclosed
US-20220267652-A1 ONE-PART ADHESIVE FOR THERMOPLASTIC URETHANES LORD CORPORATION 2022-08-25 US disclosed
EP-3583149-B1 ADHESIVE COMPOSITIONS BASED ON GRAFTED RESINS LORD CORP (US) 2022-07-27 EP disclosed
US-11279861-B2 Adhesive compositions based on grafted resins LORD CORPORATION (US) 2022-03-22 US disclosed
CN-114207074-A Single-component adhesive for thermoplastic polyurethanes 洛德公司 2022-03-18 CN disclosed
CN-110392708-B Adhesive composition based on grafted resins 洛德公司 2021-11-09 CN disclosed
US-20210043974-A1 ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE DAIKIN INDUSTRIES, LTD. (JP) 2021-02-11 US disclosed
US-20180244965-A1 ADHESIVE COMPOSITION AND METHOD FOR BONDING LORD CORPORATION (US) 2018-08-30 US disclosed
WO-2018152489-A1 ADHESIVE COMPOSITIONS BASED ON GRAFTED RESINS LORD CORPORATION (US) 2018-08-23 WO disclosed
EP-3353257-A1 ADHESIVE COMPOSITION AND METHOD FOR BONDING LORD Corporation (US) 2018-08-01 EP disclosed
CN-108026425-A adhesive composition and bonding method 洛德公司 2018-05-11 CN disclosed
WO-2017053402-A1 ADHESIVE COMPOSITION AND METHOD FOR BONDING LORD CORPORATION (US) 2017-03-30 WO disclosed
US-8058382-B2 Uretdione formation in solution BAYER MATERIALSCIENCE AG (DE) 2011-11-15 US disclosed
US-20060173152-A1 Uretdione formation in solution BAYER MATERIALSCIENCE AG 2006-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600887-B2 One-part adhesive for thermoplastic urethanes TET3, TET1, KDM3A POLB 2715/4885L3MBTL1 2940/4885GAA 4675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.